BAC
Bank of America Corporation
BAC has lower modeled downside risk, despite its lower overall score.
LOB
Live Oak Bancshares, Inc.
LOB has the edge over BAC overall, supported by stronger valuation and stronger modeled upside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
LOB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
LOB's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like LOB.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over LOB in the historical PE scenario, which offers more potential upside but is not a forecast.
LOB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.1x | $34.63 | — |
| Cheap | 11x | $30.19 | -13% |
| Current | 12x | $34.63 | — |
| Fair | 21x | $58.49 | +69% |
| Expensive | 34x | $97.13 | +180% |
Historical ranges are pointers, not guarantees.
LOB's PE is in its cheap range at 12x. If earnings grow as analysts expect, today's price would be 9.1x next year's earnings.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
LOB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for LOB, with profitability improving.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over LOB on earnings, with more consistent year-over-year improvement.
LOB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.81 | +35% |
| Q3 2026 | $2.82 | +89% |
| Q2 2026 | $2.85 | +134% |
| Q1 2026 | $2.62 | +102% |
| Q4 2025 | $2.23 | +32% |
| Q3 2025 | $1.49 | -19% |
| Q2 2025 | $1.22 | -50% |
| Q1 2025 | $1.30 | -42% |
| Q4 2024 | $1.69 | +3% |
LOB's earnings per share have fallen from their peak: $2.82 over the past year, against $4.54 in late 2022.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over LOB on profitability, with a higher operating margin.
LOB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $175.6M | +20% |
| Q2 2026 | $156.1M | +8.6% |
| Q1 2026 | $145.5M | +15% |
| Q4 2025 | $161.9M | +26% |
| Q3 2025 | $146.1M | +12% |
| Q2 2025 | $143.7M | +15% |
| Q1 2025 | $126.1M | +8.5% |
| Q4 2024 | $128.1M | +7% |
LOB has the edge over BAC on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | -5 points |
| Q2 2026 | 29% | +7.6 points |
| Q1 2026 | 28% | +17 points |
| Q4 2025 | 38% | +28 points |
| Q3 2025 | 25% | +11 points |
| Q2 2025 | 22% | -7 points |
| Q1 2025 | 10% | -8.6 points |
| Q4 2024 | 10% | -4.3 points |
LOB's operating margin was 20% last quarter, down 5 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
LOB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $124.4M | +105% |
| Q2 2026 | $28.4M | -86% |
| Q1 2026 | $85.3M | -17% |
| Q4 2025 | $70.4M | +$294.5M |
| Q3 2025 | $60.6M | -67% |
| Q2 2025 | $206.7M | +210% |
| Q1 2025 | $102.7M | +48% |
| Q4 2024 | -$224.2M | -251% |
LOB's free cash flow was $309M over the past year, up 112% from the year before. Free cash flow isn't a meaningful measure for financial services companies like LOB.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over LOB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
LOB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +275K shares |
| 1 year | +1.4% | +652K shares |
| 3 years | +3.5% | +1.6M shares |
| 5 years | +4.9% | +2.2M shares |
| Available history | +14% | +5.8M shares |
LOB has 47M diluted shares, up 1.4% from a year ago.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
LOB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.2x | Net Cash |
| Q2 2026 | -4.3x | Net Cash |
| Q1 2026 | -4.1x | Net Cash |
| Q4 2025 | -5.0x | Net Cash |
| Q3 2025 | -7.4x | Net Cash |
| Q2 2025 | -6.5x | Net Cash |
| Q1 2025 | -7.1x | Net Cash |
| Q4 2024 | -5.4x | Net Cash |
LOB has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
LOB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.3 | Neutral |
| Stochastic | 9.6 | Oversold |
LOB's weekly RSI is 38 (neutral) and its Stochastic is 10 (oversold).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over LOB on valuation relative to its sector.
LOB PE vs Financial Services Sector
| Metric | LOB | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 5.7% below |
| PE % | 19 | 63 | 44 pts below |
LOB is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has the edge over LOB on trend strength, trading above more of its moving averages.
LOB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $35.2 | 1.7% below |
| 20 week MA | $38.8 | 11% below |
| 50 week MA | $37.6 | 7.8% below |
| 100 week MA | $34.8 | 0.6% below |
| 200 week MA | $35.2 | 1.5% below |
LOB is in a downtrend: it's below all five of its weekly moving averages, and 1.5% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
LOB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.1 | $48.1 | +153% |
| 2021 | $48.1 | $83.7 | +74% |
| 2022 | $83.7 | $31.4 | -62% |
| 2023 | $31.4 | $45.5 | +45% |
| 2024 | $45.5 | $39.4 | -13% |
| 2025 | $39.4 | $35.2 | -11% |
| 2026 YTD | $35.2 | $34.6 | -1.6% |
LOB has the edge over BAC on returns for 2026, with the stronger performance.